Evidence map›Paper›PMID 30714803›Full record

ArticleBehavioral neuroscience2019

The effects of clavulanic acid and amoxicillin on cue-primed reinstatement of cocaine seeking.

Allison R Bechard, Peter U Hamor, Lizhen Wu, Marek Schwendt, Lori A Knackstedt

Open access · hybridAbstract read
In one paragraph

Article in Behavioral neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Clavulanic acid prevents paclitaxel-induced neuropathic pain through a systemic and central anti-inflammatory effect in mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. MC-100093, a NovelThe Journal of pharmacology and experimental therapeutics · 2021
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Allison R BechardDepartment of Psychology, University of Florida.
Peter U HamorDepartment of Psychology, University of Florida.
Lizhen WuDepartment of Psychology, University of Florida.
Marek SchwendtDepartment of Psychology, University of Florida.
Lori A KnackstedtDepartment of Psychology, University of Florida.
University of Florida · US

Funding

GLT-1 Enhancers as Drug Candidates for Treating Cocaine AddictionR01DA037270 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ABOU-GHARBIA, MAGID, ROTHSTEIN, JEFFREY D · 2014 to 2018
$2.0M
Glutamate Transporters and Cocaine SeekingR01DA033436 · NIDA · UNIVERSITY OF FLORIDA · PI KNACKSTEDT, LORI A · 2012 to 2016
$1.3M
Institute on Molecular NeuroscienceNational Institutes of HealthNIDA NIH HHS R01 DA033436NIDA NIH HHS R01 DA037270U.S. Army Medical Research Acquisition Activity
6 · The paper itself

Abstract

Research using the cocaine self-administration and reinstatement animal model of relapse finds that the beta-lactam antibiotic, ceftriaxone, attenuates cocaine-primed reinstatement of cocaine seeking and upregulates two proteins that regulate glutamate release and reuptake (xCT and GLT-1, respectively) in the nucleus accumbens core (NAc). We tested three compounds with beta-lactam rings for their ability to attenuate cue-primed reinstatement and increase GLT-1 and xCT expression in the NAc and prefrontal cortex (PFC). Rats self-administered intravenous cocaine for 1 hr/day for 7 days then 6 hrs/day for 10 days. Cue-primed reinstatement tests began after 8-9 days of extinction training. Rats received oral vehicle, clavulanic acid (CA), amoxicillin (AMX), or CA + AMX (Augmentin; AUG) for 5 days prior to testing. Only AMX-treated rats demonstrated a reduction of cocaine-seeking that trended toward significance, warranting future investigation of a wider range of doses. In the NAc, GLT-1a expression was reduced in vehicle-treated rats relative to cocaine-naïve controls and was not restored by AMX or AUG. CA-treated rats reinstated more than vehicle-treated rats and exhibited GLT-1a and xCT expression intermediate between cocaine-naïve controls and vehicle-treated cocaine rats. In agreement with our previous work, cocaine did not decrease PFC GLT-1a expression. Cocaine reduced xCT expression in the PFC that was unchanged by any of the three compounds. These results indicate that AMX may be another beta-lactam that attenuates cocaine relapse. Furthermore, the upregulation of both GLT-1 and xCT in the NAc may be needed to attenuate cocaine seeking. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Indexed as

Amino Acid Transport Systems, AcidicAmino Acid Transport System y+AmoxicillinAnimalsAnti-Bacterial Agentsbeta-Lactamase InhibitorsClavulanic AcidCocaineCuesDrug-Seeking BehaviorExcitatory Amino Acid Transporter 2Extinction, PsychologicalMaleNucleus AccumbensPrefrontal CortexRats, Sprague-DawleyAmino Acid Transport Systems, AcidicAmino Acid Transport System y+AmoxicillinAnti-Bacterial Agentsbeta-Lactamase InhibitorsClavulanic AcidCocaineExcitatory Amino Acid Transporter 2Slc1a2 protein, ratSlc7a11 protein, rat

Identifiers

PMID30714803
PMCPMC6508097
OpenAlexW2914871629

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.